ADAR1

Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Marketscreener
Tue, 03/28/23 - 10:20 am
Covant Therapeutics
drug discovery
R&D
Boehringer Ingelheim
cancer
ADAR1